|
Biotech
Advisory Board: Offering Advice to Kellogg's Biotechnology Center
The distinguished
group of national and local advisors for Kellogg's Center
for Biotechnology have met twice, April 27th and November
6, 2001. Arthur Holden '88 serves as Board Chairman of the
group. The advisors have provided insight into the development
of the biotech major and the center's first executive education
program, "Strategies for Value Creation in Biotechnology"
(offered September 26-29, 2001 at the James L. Allen Center).
The November meeting focused on managing growth and expectations,
and determining research priorities for the biotech industry.
Kellogg
Center for Biotechnology Advisory Board:
D. Ted
Berghorst, Founding Chairman/CEO, Prudential Vector Securities
Mark Booth, Executive Vice President, Takeda Pharmaceutical
Company
Steven Burrill, EO, President and Chairman, Burrill and Co.
Richard Brewer, CEO and President, Scios
Karen Daniels, Vice President of Aranesp Brand Management,
Amgen, Inc.
James Daverman, Founder, Marquette Venture Partners
Carl Feldbaum, President, Biotechnology Industry Organization
(BIO)
David Flores, President and CEO, BioCentury
Wilbur Gantz, President, Gantz Enterprises
Winton Gibbons, Partner, William Blair & Co.
Lewis Gruber, Partner, Sonnenschien, Nath and Carlin
Scott Halsted, VP, Healthcare, Morgan Stanley Dean Witter
Albert J. Henry, Chairman, Henry & Company
Elliott Hillback, Jr. Senior VP, Corporate Affairs, Genzyme
Corp.
Arthur Holden, CEO, SNP Consortium, Chairman and CEO, First
Genetic Trust, Inc.
James Isono, Partner, McKinsey & Co.
Harry Kraemer, CEO & President, Baxter Healthcare
Bruno Larvol, President & CEO, Nufinity Inc.
Joe Marek, CEO, Midwest Heart Specialists
John McDonnell, Founding Partner, McDonnell, Boehnen, Hulbert
& Berghoff
Scott Minick, Partner, Arch Venture Partners
Nick Naclerio, Senior Vice President/Chief Business Officer,
Zyomyx Inc.
Arthur Pancoe, Senior Managing Director, Bear Stearns &
Co.
H. Stewart Parker, President and CEO, Targeted Genetics
Richard Pilnick, VP, Global Marketing, Eli Lilly
Spiro Rombotis, CEO, Cyclacel Limited
Pablo Valenzuela, Chairman, Chiron Corporation
Michael Webb, CEO, EPIX Medical, Inc.
Tony White, CEO, Applera
Kellogg
Center for Biotechnology Alumni Representatives:
Chris
Erlich, Interwest Partners
Ted Davis, Vector Fund
Marc Galletti, Amerindo Investments
Ex
Officio:
Donald
P. Jacobs, Dean Emeritus, Kellogg School of Management, Northwestern
University
Lydia Villa-Komaroff, Vice President, Research, Northwestern
University
Joel Shalowitz, Director, Health Industry Management Program,
Kellogg School of Management, Northwestern University
Lloyd Shefsky, Lloyd E. Shefsky, LTD, and Clinical Professor,
Kellogg School of Management, Northwestern University
Richard Morimoto, John Evans Professor of Biochemistry, Molecular,
Cell Biology; Dean, Graduate School, Northwestern University
|